These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


790 related items for PubMed ID: 24921459

  • 21. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [Abstract] [Full Text] [Related]

  • 22. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
    Cotté FE, Chaize G, Kachaner I, Gaudin AF, Vainchtock A, Durand-Zaleski I.
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623
    [Abstract] [Full Text] [Related]

  • 23. A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects.
    Li YG, Pastori D, Farcomeni A, Yang PS, Jang E, Joung B, Wang YT, Guo YT, Lip GYH.
    Chest; 2019 Mar; 155(3):510-518. PubMed ID: 30292759
    [Abstract] [Full Text] [Related]

  • 24. Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: The Australian Diabetes, Obesity and Lifestyle (AusDiab) longitudinal, population cohort study.
    Diouf I, Magliano DJ, Carrington MJ, Stewart S, Shaw JE.
    Int J Cardiol; 2016 Feb 15; 205():127-132. PubMed ID: 26730844
    [Abstract] [Full Text] [Related]

  • 25. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM.
    Cerebrovasc Dis; 2013 Feb 15; 36(4):273-80. PubMed ID: 24135809
    [Abstract] [Full Text] [Related]

  • 26. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS, Polovina MM, Marinkovic JM, Lip GY.
    Int J Cardiol; 2013 Oct 12; 168(5):4744-9. PubMed ID: 23958417
    [Abstract] [Full Text] [Related]

  • 27. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul 12; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.
    Glotzer TV, Hellkamp AS, Lee KL, Lamas GA.
    Can J Cardiol; 2015 Aug 12; 31(8):1004-11. PubMed ID: 26076964
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population Study.
    Hayden DT, Hannon N, Callaly E, Ní Chróinín D, Horgan G, Kyne L, Duggan J, Dolan E, O'Rourke K, Williams D, Murphy S, Kelly PJ.
    Stroke; 2015 Dec 12; 46(12):3488-93. PubMed ID: 26470776
    [Abstract] [Full Text] [Related]

  • 32. Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.
    Zhang H, Yang Y, Zhu J, Shao X, Liu Y, Zhao L, Yu P, Zhang H, He Q, Gu X.
    Intern Med J; 2014 Aug 12; 44(8):742-8. PubMed ID: 24893684
    [Abstract] [Full Text] [Related]

  • 33. Usefulness of a Combination of Interatrial Block and a High CHADS2 Score to Predict New Onset Atrial Fibrillation.
    Wu JT, Wang SL, Chu YJ, Long DY, Dong JZ, Fan XW, Yang HT, Duan HY, Yan LJ, Qian P, Yang CK.
    Int Heart J; 2016 Sep 28; 57(5):580-5. PubMed ID: 27593538
    [Abstract] [Full Text] [Related]

  • 34. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L, Lecoq C, Clementy N, Bernard A, Angoulvant D, Ivanes F, Babuty D, Lip GY.
    Chest; 2016 Apr 28; 149(4):960-8. PubMed ID: 26425935
    [Abstract] [Full Text] [Related]

  • 35. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Lip GY.
    Eur J Heart Fail; 2013 Apr 28; 15(4):415-24. PubMed ID: 23302606
    [Abstract] [Full Text] [Related]

  • 36. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
    Baturova MA, Lindgren A, Carlson J, Shubik YV, Olsson SB, Platonov PG.
    Int J Cardiol; 2015 Nov 15; 199():248-52. PubMed ID: 26209828
    [Abstract] [Full Text] [Related]

  • 37. Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study.
    Lai HC, Chien WC, Chung CH, Lee WL, Wang KY, Wu TJ, Liu CN, Liu TJ.
    Int J Cardiol; 2015 Oct 15; 197():133-9. PubMed ID: 26126057
    [Abstract] [Full Text] [Related]

  • 38. Bleeding as an outcome among patients with nonvalvular atrial fibrillation in a large managed care population.
    Deitelzweig SB, Pinsky B, Buysman E, Lacey M, Makenbaeva D, Wiederkehr D, Graham J.
    Clin Ther; 2013 Oct 15; 35(10):1536-45.e1. PubMed ID: 24075151
    [Abstract] [Full Text] [Related]

  • 39. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.
    Europace; 2014 Feb 15; 16(2):202-7. PubMed ID: 23813452
    [Abstract] [Full Text] [Related]

  • 40. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
    Lip GY, Skjøth F, Rasmussen LH, Larsen TB.
    J Am Coll Cardiol; 2015 Apr 14; 65(14):1385-94. PubMed ID: 25770314
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 40.